Evommune, Inc. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   EVO756 · Atopic Dermatitis

   Trial completed

   Evommune, Inc.·Phase 2· NCT07150845· Registry history of NCT07150845 on ClinicalTrials.gov (opens the registry)

   Oct 2, 2026

2. Minor

   EVO756 · Migraine

   Trial sites expanded: 26 → 35 locations

   Evommune, Inc.·Phase 2· NCT07616128· Registry history of NCT07616128 on ClinicalTrials.gov (opens the registry)

   Oct 2, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.